4//SEC Filing
Harford Simon N.R. 4
Accession 0000950170-25-002421
CIK 0001178879other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:02 PM ET
Size
8.5 KB
Accession
0000950170-25-002421
Insider Transaction Report
Form 4
Harford Simon N.R.
Chief Financial Officer
Transactions
- Award
Stock Options (right to buy)
2025-01-03+150,517→ 150,517 totalExercise: $9.41Exp: 2035-01-03→ Common Stock (150,517 underlying) - Award
Common Stock
2025-01-03+83,073→ 227,427 total - Tax Payment
Common Stock
2025-01-02$9.31/sh−7,482$69,657→ 144,354 total
Footnotes (2)
- [F1]Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on January 3, 2026 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
- [F2]These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.
Documents
Issuer
AMICUS THERAPEUTICS, INC.
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001443705
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:02 PM ET
- Size
- 8.5 KB